##plugins.themes.academic_pro.article.main##

Abstract

Worldwide, according to statistics (WHO), 47.5 million people suffer from dementia, and 7.7 million new cases are detected every year. By 2050, the world is expected to have 140 million patients, that is, approximately three times more than today. “...Much of the increase is due to an increase in the number of people with dementia living in low- and middle-income countries...” Dementia is considered the main cause of disability among the elderly and senile people worldwide. Despite the availability of a large number of nootropic drugs with different mechanisms of action, they are mostly imported at high cost, are aimed at a specific mechanism for the development of hypoxia and dementia, and are not available to the middle and lower strata of the population. In this regard, one of the urgent tasks that meets the standards of today's medicine is the creation of new complex nootropic drugs with combined effects, the study of specific and toxicological characteristics, as well as the molecular mechanisms of antihypoxic action.

Keywords

Nootropic drugs hypoxia

##plugins.themes.academic_pro.article.details##

How to Cite
Kasimov E.R, & Akhmedova D.B. (2023). Experimental Study of Combined Nootropic Drugs on Glucose Levels During the Development of Hemic Hypoxia. Zien Journal of Social Sciences and Humanities, 25, 14–16. Retrieved from https://zienjournals.com/index.php/zjssh/article/view/4495

References

  1. Galochkin V. A., Malinenko P. E., Maistrov V. I. The glutathione system as a criterion for the antioxidant status of animals // Proceedings of the All-Russian Scientific Research Institute of Physiology, Biochemistry and Agricultural Nutrition. – 2005. – P. 98.
  2. Demidovich A.P. Diagnostic value of biochemical blood parameters (protein, carbohydrate, lipid metabolism). – 2019.
  3. Kurbanov A. A. Laboratory workshop on studying the process of glycolysis using the benzocaine method for determining glucose // Issues of science and education. – 2017. – No. 11 (12). – pp. 27-37.
  4. Lutsenko M. T., Andrievskaya I. A. Morphofunctional changes in erythroid elements in normal conditions and in pathology. – 2015.
  5. Levchenkova O. S., Novikov V. E., Pozhilova E. V. Pharmacodynamics and clinical use of antihypoxants // Reviews on clinical pharmacology and drug therapy. – 2012. – T. 10. – No. 3. – P. 3-12.
  6. Samokhvalov V. G. et al. Physiology of metabolism and energy. Thermoregulation. – 2005.